Bristol-Myers Squibb Co (NYSE:BMY)
| 58.23 Delayed Data As of Apr 08 |  -0.02 / -0.03%Today’s Change | 42.48 Today|||52-Week Range 68.34 | -9.28% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 58.25 |
| Today’s open | 57.09 |
| Day’s range | 56.37 - 58.80 |
| Volume | 928 |
| Average volume (3 months) | 16,301,869 |
| Market cap | $124.8B |
Data as of 7:55pm ET, 04/08/2020
Growth & Valuation
| Earnings growth (last year) | -33.05% |
| Earnings growth (this year) | +32.02% |
| Earnings growth (next 5 years) | +9.76% |
| Revenue growth (last year) | +15.89% |
| P/E ratio | 29.0 |
| Price/Sales | 4.20 |
| Price/Book | 2.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | -0.19 | -0.13% |
| ABBVAbbVie | -0.04 | -0.05% |
| AZNAstraZeneca | -0.03 | -0.07% |
| SNYSanofi | +0.58 | +1.30% |
Data as of 4:00pm ET, 04/08/2020
Financials
| Next reporting date | April 23, 2020 |
| EPS forecast (this quarter) | $1.45 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 13.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
